61 related articles for article (PubMed ID: 19292045)
1. [Expression of glomerular heparan sulfate domains in pediatric patients with minimal change nephrotic syndrome].
Dong LQ; Wang Z; Yu P; Guo YN; Wu J; Feng SP; Li S
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Jan; 40(1):55-8. PubMed ID: 19292045
[TBL] [Abstract][Full Text] [Related]
2. Adult and paediatric patients with minimal change nephrotic syndrome show no major alterations in glomerular expression of sulphated heparan sulphate domains.
Wijnhoven TJ; Geelen JM; Bakker M; Lensen JF; Rops AL; Kramer AB; Navis G; van den Hoven MJ; van der Vlag J; Berden JH; Wetzels JF; van den Heuvel LP; Monnens LA; van Kuppevelt TH
Nephrol Dial Transplant; 2007 Oct; 22(10):2886-93. PubMed ID: 17526541
[TBL] [Abstract][Full Text] [Related]
3. Expression of glomerular heparan sulphate domains in murine and human lupus nephritis.
Rops AL; van den Hoven MJ; Bakker MA; Lensen JF; Wijnhoven TJ; van den Heuvel LP; van Kuppevelt TH; van der Vlag J; Berden JH
Nephrol Dial Transplant; 2007 Jul; 22(7):1891-902. PubMed ID: 17550924
[TBL] [Abstract][Full Text] [Related]
4. Urine glycosaminoglycans and heparan sulfate excretions in adult patients with glomerular diseases.
Mitsuhashi H; Tsukada Y; Ono K; Yano S; Naruse T
Clin Nephrol; 1993 May; 39(5):231-8. PubMed ID: 8513598
[TBL] [Abstract][Full Text] [Related]
5. Production and characterization of a monoclonal antibody against human glomerular heparan sulfate.
van den Born J; van den Heuvel LP; Bakker MA; Veerkamp JH; Assmann KJ; Berden JH
Lab Invest; 1991 Sep; 65(3):287-97. PubMed ID: 1890809
[TBL] [Abstract][Full Text] [Related]
6. Heparan sulfate staining of the glomerular basement membrane in relation to circulating anti-DNA and anti-heparan sulfate reactivity: a longitudinal study in NZB/W F1 mice.
Hylkema MN; van Bruggen MC; van de Lagemaat R; Kramers K; Berden JH; Smeenk RJ
J Autoimmun; 1996 Feb; 9(1):41-50. PubMed ID: 8845053
[TBL] [Abstract][Full Text] [Related]
7. Loss of heparan sulfate proteoglycan from glomerular basement membrane of nephrotic rats.
Mynderse LA; Hassell JR; Kleinman HK; Martin GR; Martinez-Hernandez A
Lab Invest; 1983 Mar; 48(3):292-302. PubMed ID: 6219248
[TBL] [Abstract][Full Text] [Related]
8. Serum and urinary concentrations of heparan sulfate in patients with diabetic nephropathy.
Yokoyama H; Sato K; Okudaira M; Morita C; Takahashi C; Suzuki D; Sakai H; Iwamoto Y
Kidney Int; 1999 Aug; 56(2):650-8. PubMed ID: 10432405
[TBL] [Abstract][Full Text] [Related]
9. Alterations in proteoglycan metabolism in the nephrotic syndrome induced by the aminonucleoside of puromycin.
Klein DJ; Dehnel PJ; Oegema TR; Brown DM
Lab Invest; 1984 May; 50(5):543-51. PubMed ID: 6232422
[TBL] [Abstract][Full Text] [Related]
10. Glomerular and urinary heparan sulphate in congenital nephrotic syndrome.
Vermylen C; Levin M; Mossman J; Barratt TM
Pediatr Nephrol; 1989 Apr; 3(2):122-9. PubMed ID: 2534970
[TBL] [Abstract][Full Text] [Related]
11. Glomerular basement membrane heparan sulfate glycosaminoglycan in aminonucleoside of puromycin nephrosis.
Garin EH; Shirey AJ
Child Nephrol Urol; 1988-1989; 9(3):121-6. PubMed ID: 2978121
[TBL] [Abstract][Full Text] [Related]
12. Hydroxyl radicals depolymerize glomerular heparan sulfate in vitro and in experimental nephrotic syndrome.
Raats CJ; Bakker MA; van den Born J; Berden JH
J Biol Chem; 1997 Oct; 272(42):26734-41. PubMed ID: 9334259
[TBL] [Abstract][Full Text] [Related]
13. Noncollagenous matrix components of glomeruli in congenital nephrotic syndrome of the Finnish type: evidence of abnormal splitting of nidogen?
Ljungberg P; Haltia A; Kuusela P; Jalanko H; Holmberg C; Holthöfer H
Exp Nephrol; 1996; 4(5):286-94. PubMed ID: 8931984
[TBL] [Abstract][Full Text] [Related]
14. Decrease of heparan sulfate staining in the glomerular basement membrane in murine lupus nephritis.
van Bruggen MC; Kramers K; Hylkema MN; van den Born J; Bakker MA; Assmann KJ; Smeenk RJ; Berden JH
Am J Pathol; 1995 Mar; 146(3):753-63. PubMed ID: 7534044
[TBL] [Abstract][Full Text] [Related]
15. Glomerular anionic sites in minimal change nephrotic syndrome and focal segmental glomerulosclerosis.
Kitano Y; Yoshikawa N; Nakamura H
Clin Nephrol; 1993 Oct; 40(4):199-204. PubMed ID: 8261675
[TBL] [Abstract][Full Text] [Related]
16. Role of cyclic AMP in idiopathic nephrotic syndrome: a pathway involving a decrease in glomerular cell heparan sulfates?
Birmelé B; De Agostini A; Girardin EP
J Cell Biochem; 2000 Jun; 78(3):363-70. PubMed ID: 10861835
[TBL] [Abstract][Full Text] [Related]
17. In vivo degradation of heparan sulfates in the glomerular basement membrane does not result in proteinuria.
Wijnhoven TJ; Lensen JF; Wismans RG; Lamrani M; Monnens LA; Wevers RA; Rops AL; van der Vlag J; Berden JH; van den Heuvel LP; van Kuppevelt TH
J Am Soc Nephrol; 2007 Mar; 18(3):823-32. PubMed ID: 17251387
[TBL] [Abstract][Full Text] [Related]
18. Novel heparan sulfate structures revealed by monoclonal antibodies.
van den Born J; Salmivirta K; Henttinen T; Ostman N; Ishimaru T; Miyaura S; Yoshida K; Salmivirta M
J Biol Chem; 2005 May; 280(21):20516-23. PubMed ID: 15778504
[TBL] [Abstract][Full Text] [Related]
19. Basic fibroblast growth factor-binding domain of heparan sulfate in the human glomerulosclerosis and renal tubulointerstitial fibrosis.
Morita H; Shinzato T; David G; Mizutani A; Habuchi H; Fujita Y; Ito M; Asai J; Maeda K; Kimata K
Lab Invest; 1994 Oct; 71(4):528-35. PubMed ID: 7967508
[TBL] [Abstract][Full Text] [Related]
20. Removal of heparan sulfate from the glomerular basement membrane blocks protein passage.
Wijnhoven TJ; Lensen JF; Wismans RG; Lefeber DJ; Rops AL; van der Vlag J; Berden JH; van den Heuvel LP; van Kuppevelt TH
J Am Soc Nephrol; 2007 Dec; 18(12):3119-27. PubMed ID: 18003778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
